ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.
FOURTH QUARTER 2012 SUMMARY
• Total revenue of $96.9 million.
• Income from operations of $15.1 million, or operating margin of 15.6 percent.
• Net income applicable to common stockholders of $10.3 million, or $0.30 per diluted share.
